CAPFX
Price
$9.21
Change
+$0.01 (+0.11%)
Updated
Sep 5 closing price
Net Assets
679.16M
HBLSX
Price
$15.17
Change
+$0.03 (+0.20%)
Updated
Sep 5 closing price
Net Assets
11.94B
Interact to see
Advertisement

CAPFX vs HBLSX

Header iconCAPFX vs HBLSX Comparison
Open Charts CAPFX vs HBLSXBanner chart's image
Federated Hermes Capital Income F
Price$9.21
Change+$0.01 (+0.11%)
VolumeN/A
Net Assets679.16M
Hartford Balanced Income R4
Price$15.17
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets11.94B
CAPFX vs HBLSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CAPFX vs. HBLSX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPFX is a Hold and HBLSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLSX has more cash in the bank: 11.9B vs. CAPFX (679M). CAPFX (3.22) and HBLSX (3.17) have matching dividends . CAPFX was incepted earlier than HBLSX: CAPFX (29 years) vs HBLSX (15 years). CAPFX (1.10) is less costly to investors than HBLSX (0.96). HBLSX is a more actively managed with annual turnover of: 61.00 vs. CAPFX (31.00). HBLSX has a lower initial minimum investment than CAPFX: HBLSX (0) vs CAPFX (1500). CAPFX annual gain was more profitable for investors over the last year : 10.50 vs. HBLSX (3.49). CAPFX return over 5 years is better than : 36.38 vs. HBLSX (16.03).
CAPFXHBLSXCAPFX / HBLSX
Total Expense Ratio0.900.9694%
Annual Report Gross Expense Ratio1.100.96115%
Fund Existence29 years15 years-
Gain YTD8.7518.163107%
Front Load1%N/A-
Min. Initial Investment15000-
Min. Initial Investment IRA250N/A-
Net Assets679M11.9B6%
Annual Yield % from dividends3.223.17102%
Returns for 1 year10.503.49301%
Returns for 3 years32.1018.48174%
Returns for 5 years36.3816.03227%
Returns for 10 years68.2346.85146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT7.270.66
+9.98%
4D Molecular Therapeutics
AGCO111.021.33
+1.21%
AGCO Corp
TILE28.180.30
+1.08%
Interface
FVNNU10.50N/A
N/A
Future Vision II Acquisition Corp.
CLST13.10-0.05
-0.38%
Catalyst Bancorp